Warning

Duration

Mild-Moderate Cellulitis: 5 days 

Moderate to Severe Cellulitis/Erysipelas: IV / oral 7-14 days depending on clinical progress

Mild-Moderate Cellulitis

Important: Therapy

Oral Flucloxacillin5 500mg - 1g 6 hourly 

 

Penicillin allergy  
Oral Doxycycline2, 9 100mg 12 hourly 
OR
Oral Co-trimoxazole 2,10,12,13 960mg 12 hourly

Notes:

Total duration:5 days

Moderate to Severe Cellulitis/Erysipelas

Important: Therapy

IV Flucloxacillin5, 10 1-2g 6 hourly 

Stepping down to:
Oral Flucloxacillin 1g 6 hourly

 

Penicillin allergy or MRSA suspected 
IV Vancomycin3

Stepping down to:
Oral Doxycycline2,9 100mg 12 hourly

Notes:

For upper limb cellulitis seek advice from Orthopaedics

Total duration: IV / oral 7-14 days depending on clinical progress

Important: Notes

Doses may need to be adjusted in renal impairment. Always check the BNF for interactions. Seek advice if patient pregnant.

Drug Specific Cautions:

  1. Check interactions in the BNF. Caution may prolong QT interval.
  2. Avoid / Caution in pregnancy or breastfeeding. Consult BNF for details.
  3. Gentamicin/Vancomycin refer to online calculators.
  4. ALERT Antibiotic - Consult Second line Policy on NHS Lanarkshire Guideline App.
  5. Monitor sodium.
  6. See CURB65 definition.
  7. Reference: The Renal Drug Handbook. Online access.
  8. See Fluoroquinolones MHRA guidance on NHS Lanarkshire Guidelines App.
  9. Doxycycline and quinolones decreased absorption with iron, calcium, magnesium and some nutritional supplements. See BNF appendix 1 or pharmacy for advice.
  10. Caution in renal impairment – see BNF or pharmacy for advice.
  11. Use with caution may increase K+ and decrease renal function. Monitor.
  12. High / Excellent oral bioavailability, IV route available for NBM or vomiting.
  13. See Co-trimoxazole information for prescribers’ safety sheet on NHS Lanarkshire Guidelines App.

Editorial Information

Last reviewed: 01/12/2022

Next review date: 01/12/2025

Author(s): NHS Lanarkshire Antimicrobial Management Committee, Dr Dundas, Dr Hylands, S McCormick.

Approved By: NHS Lanarkshire Antimicrobial Management Committee

Reviewer name(s): NHS Lanarkshire Antimicrobial Management Committee.

Document Id: March 2023